Studie
Senolytika decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
PRIMÄR
Tier 4
2019
StudiedesignPRIMÄR
TierTier 4, Animal or preclinical only
År2019
TidskriftEBioMedicine
N1
Tillagd i NO1GEVITYjun 11, 2026
Citerad av
1 encyklopediartiklar refererar till denna studie.